Evidence map›Paper›PMID 29069141›Full record

ArticleEinstein (Sao Paulo, Brazil)2018

Intra-arterial fibrinolysis for the management of acute ischemia on a below-knee amputation stump. Case report.

Breno Boueri Affonso, Joaquim Maurício da Motta Leal Filho, Rafael Noronha Cavalcante, Priscila Mina Falsarella, Francisco Leonardo Galastri, Rodolfo Souza Cardoso, Felipe Nasser

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 64% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Breno Boueri AffonsoHospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Joaquim Maurício da Motta Leal FilhoHospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Rafael Noronha CavalcanteHospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Priscila Mina FalsarellaHospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Francisco Leonardo GalastriHospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Rodolfo Souza CardosoFaculdade de Medicina de Itajubá, Itajubá, MG, Brazil.
Felipe NasserHospital Israelita Albert Einstein, São Paulo, SP, Brazil.
Hospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preservation of the knee joint has enormous advantages in terms of mobility and rehabilitation of an amputee. Any cause of breakdown requiring revision to an above-knee amputation is a major setback because it reduces the patient's rehabilitative potential. We report a case of intra-arterial thrombolysis use to save a below-knee amputation stump with acute ischemia. A 56-year-old man who sought the emergency department with 1-day history of acute pain on his right below-knee stump. The angiography confirmed popliteal artery occlusion. Pharmacomechanical thrombectomy, with Aspirex (rotational catheter to restore blood flow in occluded vessel, by removing occlusion material from the vessel) and recombinant tissue plasminogen activator, was performed. After 9 years of follow-up the patient remained asymptomatic, capable of independent ambulation with prosthetic limb. Intra-arterial fibrinolysis seems to be a safe and effective treatment for cases of acutely ischemic amputation stump.

Indexed as

Acute DiseaseAmputation StumpsFibrinolytic AgentsHumansInfusions, Intra-ArterialIschemiaMaleMiddle AgedTreatment OutcomeFibrinolytic Agents

Identifiers

PMID29069141
PMCPMC6066151
OpenAlexW2980487741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.